Increased accumulation of the glycoxidation product Nε-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody
- 6 February 2004
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1636 (2-3) , 82-89
- https://doi.org/10.1016/j.bbalip.2003.07.002
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Advanced glycation end products and diabetic complicationsExpert Opinion on Investigational Drugs, 2002
- Glycemic Control and Heart Failure Among Adult Patients With DiabetesCirculation, 2001
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ, 2000
- Hydroxyl Radical Mediates Nϵ-(Carboxymethyl)lysine Formation from Amadori ProductBiochemical and Biophysical Research Communications, 1997
- The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation ReactionsJournal of Biological Chemistry, 1996
- Nε-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advanced Glycation End Products of the Maillard ReactionBiochemistry, 1996
- N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue ProteinsBiochemistry, 1995
- Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard ReactionJournal of Biological Chemistry, 1995
- Oxidation of glycated proteins: age-dependent accumulation of N.epsilon.-(carboxymethyl)lysine in lens proteinsBiochemistry, 1989
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974